Citations

Clear

3942 citation(s) found for "To, Van".

A Qualitative Assessment of Barriers, Facilitators, and Outcomes in a Simulation-Based Collaborative Quality Improvement Program
Alletag, Michelle, Kant, Shruti, Ittersum, Wendy L. Van, Walls, Theresa A. , Montgomery, Erin , Mannenbach, Mark S., Auerbach, Marc , Auerbach, Marc A, Anderson, Hannah L. Kakara

Mayo Clinic

Pediatric Emergency Care | January 9, 2025 | Volume: 41 | Issue: 4 | Pages: 273-280

10.1097/pec.0000000000003321 | PMID 39787042 Get It

Objectives: ImPACTS (Improving Acute Care Through Simulation) is a collaborative simulation-based program partnering pediatric specialty centers (“hubs”) with general emergency departments (GEDs) to improve pediatric acute care. Objective measurements of ImPACTS, such as evaluating Pediatric Readiness Score (PRS) and simulation-based outcome improvements, have been reported previously. Barriers to and facilitators of program involvement and the downstream effects of the program have not been previously described. This study explores these aspects and key drivers for successful collaboration. Methods: The authors performed open coding of semistructured interviews of hub team members and pediatric emergency care coordinators (PECCs) from community GED “spokes.” We then identified and explored themes within the categories of barriers to, facilitators of, and barrier mitigation strategies for successful partnerships from the perspectives of both groups. Results: Analysis generated 4 dominant themes: buy-in, communication, personnel, and logistics. Engagement, institutional support, and buy-in of site leaders and individual participants were crucial to successful implementation, without which the programs were not completed or never started. Hubs benefited from project involvement via increased local engagement in pediatric readiness, organizational support, and further buy-in from institutional leadership, allowing for the future continuation of ImPACTS and similar programs. Benefits experienced by GEDs impacted education, pediatric readiness, and clinical and financial partnerships across institutions. Additionally, spoke interviewees cited downstream effects of participation, including increased collaboration and improved relationships with hub sites as being the most impactful. Conclusion: Understanding the key drivers of all collaborators is instrumental in successfully implementing large-scale educational and quality initiatives like the ImPACTS program.
Connectivity as a universal predictor of tau spreading in typical and atypical Alzheimer’s disease
Bruin, Hannah de , Groot, Colin , ADNI, Barthel, Henryk , Bischof, Gérard N. , Brendel, Matthias, Dickerson, Brad C., Dyck, Christopher H van, Fredericks, Carolyn , Graff‐Radford, Jonathan, Hönig, Merle C., Jones, P Simon, Josephs, Keith A. , Katsumi, Yuta , Lee, Eddie B, McGinnis, Scott M., Mecca, Adam P. , O’Brien, John T. , Rahmouni, Nesrine , Sabri, Osama, Servaes, Stijn , Sintini, Irene , Stevenson, Jenna , Touroutoglou, Alexandra , Trainer, Anne, Whitwell, Jennifer L., O'Brien, John Tiernan , Groot, Colin , ADNI, Boellaard, Ronald , Brendel, Matthias , Cash, David M. , Coath, William , Day, Gregory S. , Doering, Elena , Drzezga, Alexander E. , Dyck, Christopher van , Eimeren, Thilo van , Flier, Wiesje M. van der , Fryer, Tim D. , Giessen, Elsmarieke van de , Gordon, Brian A. , Graff‐Radford, Jonathan , Hobbs, Diana A. , Höglinger, Günter U. , Irwin, David J. , Jones, Peter Simon , Xiong, Chengjie , Malpetti, Maura , Nasrallah, Ilya M. , O’Dell, Ryan S. , Palleis, Carla , Perneczky, Robert , Phillips, Jeffrey S , Pijnenburg, Yolande A.L. , Putcha, Deepti , Rosa-Neto, Pedro , Rowe, James B. , Rullmann, Michael , Saur, Dorothee , Schildan, Andreas , Schott, Jonathan M. , Schroeter, Matthias L , Therriault, Joseph , Visser, Denise , Weston, Philip S.J. , Whitwell, Jennifer , Wolk, David A. , Franzmeier, Nicolai , Ossenkoppele, Rik

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S2 | Pages: No page available

10.1002/alz.085869 Get It

AbstractBackgroundThere is a strong link between tau and progression of Alzheimer’s disease (AD), necessitating an understanding of tau spreading mechanisms. Prior research, predominantly in typical AD, suggested that tau propagates from epicenters (regions with earliest tau) to functionally connected regions. However, given the constrained spatial heterogeneity of tau in typical AD, validating this connectivity‐based tau spreading model in AD variants with distinct tau deposition patterns is crucial.MethodWe included 269 amyloid‐β‐positive (PET/CSF) individuals with clinically diagnosed atypical AD (113 posterior cortical atrophy, PCA‐AD; 83 logopenic variant primary progressive aphasia, lvPPA‐AD; 33 behavioural variant AD, bvAD; 40 corticobasal syndrome, CBS‐AD) and 68 with typical AD from 12 international cohorts, who underwent tau‐PET (54% [18F]AV1451/[18F]flortaucipir/Tauvid, 27% [18F]MK6240, 19% [18F]PI2620). Using Gaussian mixture modeling including amyloid‐β‐negative controls, cross‐sectional tau‐PET standardized uptake value ratios within Schaefer‐200 atlas regions were transformed to tau positivity probabilities. Tau epicenters were defined as the 5% regions with highest tau positivity probabilities. For each variant, the association between functional connectivity‐based distance (using the 30% strongest positive region‐to‐region connections of a group‐average connectivity matrix from ADNI elderly controls) and tau‐PET covariance (group‐average correlation per region pair) was assessed through linear regression, adjusting for age, sex, site, and Euclidean distance. Regions were categorized based on functional proximity to the epicenter (quartiles 1‐4) and tau positivity probabilities were assessed accordingly.ResultTau positivity probabilities matched clinical variants, with a posterior pattern in PCA‐AD, left‐hemispheric dominant pattern in lvPPA‐AD, widespread pattern in bvAD, sensorimotor cortex involvement in CBS‐AD, and temporo‐parietal predominance in typical AD (Figure 1). In line with this, tau epicenters were highly heterogeneous across variants (Figure 1). In all variants, greater tau‐PET covariance was associated with shorter functional connectivity‐based distance (Figure 2). We observed that regions in closer functional proximity to the epicenter exhibited higher tau positivity probabilities than regions functionally further away (p<0.05, Figure 3).ConclusionThis multi‐center study shows that the brain’s functional architecture serves as a universal predictor of tau spreading in AD. Since tau is a key driver of neurodegeneration and cognitive decline in AD, this finding holds potential for personalized medicine and defining participant‐specific endpoints in clinical trials.
Clinical Phenotypes of Alzheimer's Disease: Atrophy Patterns and their Pathological Correlates
Reijner, Niels , Bouwman, Maud M.A. , Guizard, Nicolas , Jubault, Thomas, Barkhof, Frederik , Gordón, Elizabeth , Barkhof, Frederik , Frigerio, Irene , Boon, Baayla D.C. , Hoozemans, Jeroen J.M. , Rozemüller, Annemieke J.M. , Bouwman, Femke H. , Berg, Wilma D. J. van de , Jonkman, Laura E.

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093721 Get It

AbstractBackgroundRecent studies highlight distinct patterns of cortical atrophy between amnestic (typical) and non‐amnestic (atypical, with subtypes: behavioural, dysexecutive, logopenic and visuospatial) clinical phenotypes of Alzheimer’s disease (AD). The current study aimed to assess regional MRI patterns of cortical atrophy across AD phenotypes, and their association with amyloid‐beta (Aß), phosphorylated tau (pTau), axonal degeneration (NfL) and microvascular deterioration (COLIV).MethodPostmortem In‐situ 3DT1 3T‐MRI data was collected for 33 AD (17 typical, 16 atypical) and 16 control brain donors. Images were segmented and AAL3 atlas regional volumes were obtained using QyScore®. At subsequent autopsy, eight brain regions were selected, immunostained for Aß (4G8), pTau (AT8), Neurofilament‐light (NFL), and Collagen‐IV (COLIV), and quantified using qupath. Group comparisons and volume‐pathology associations were analyzed using linear models and partial correlations with covariates age, sex, postmortem delay, and intracranial volume.ResultsCompared to controls, AD phenotype groups showed overall lower cortical volume, while only minor volume differences were observed between AD phenotype groups, observed primarily in limbic regions (Figure 1). Across pathological markers, AD phenotype groups showed consistently higher immunoreactivity than controls, while atypical AD showed consistently higher immunoreactivity than typical AD (Figure 2). Moreover, different patterns of pathology could be observed between atypical subtypes (e.g. distinctly higher pTau load in the occipital gyrus of the visuospatial subtype). In typical AD, global volume loss was associated with lower Aß and higher pTau, NFL and COLIV immunoreactivity, while in atypical AD, global volume loss was primarily associated with higher NFL immunoreactivity (Figure 3a). Regionally, AD phenotype differences in atrophy‐pathology association were most pronounced in the (para)hippocampal regions. This distinction was mainly characterized by negative associations for NFL and COLIV, which was only observed in typical AD (Figure 3b‐c).ConclusionAtrophy patterns between AD phenotypes showed only minor differences, potentially attributable to the on average later disease stage of the study cohort. The higher immunoreactivity for pathological markers found in atypical AD might suggest a more severe disease burden. (Para)hippocampal volume decline was associated with axonal and microvascular deterioration in typical AD, but not in the higher pathologically burdened atypical AD group, suggesting a differential susceptibility between AD phenotypes.
Connectivity as a universal predictor of tau spreading in typical and atypical Alzheimer’s disease
Bruin, Hannah de , Groot, Colin , ADNI, Barthel, Henryk , Bischof, Gérard N. , Brendel, Matthias, Dickerson, Brad C., Dyck, Christopher H van, Fredericks, Carolyn , Graff‐Radford, Jonathan, Hönig, Merle C., Jones, P Simon, Josephs, Keith A. , Katsumi, Yuta , Lee, Eddie B, McGinnis, Scott M., Mecca, Adam P. , Rahmouni, Nesrine , Servaes, Stijn , Sintini, Irene , Stevenson, Jenna , Touroutoglou, Alexandra , Trainer, Anne, Whitwell, Jennifer L., ADNI, Boellaard, Ronald , Brendel, Matthias , Cash, David M. , Coath, William , Day, Gregory S. , Doering, Elena , Drzezga, Alexander E. , Dyck, Christopher van , Eimeren, Thilo van , Flier, Wiesje M. van der , Fryer, Tim D. , Giessen, Elsmarieke van de , Gordon, Brian A. , Graff‐Radford, Jonathan , Hobbs, Diana A. , Höglinger, Günter U. , Irwin, David J. , Jones, Peter Simon , Xiong, Chengjie , Malpetti, Maura , Nasrallah, Ilya M. , O'Brien, John Tiernan , O’Dell, Ryan S. , Palleis, Carla , Perneczky, Robert , Phillips, Jeffrey S , Pijnenburg, Yolande A.L. , Putcha, Deepti , Rosa-Neto, Pedro , Rowe, James B. , Rullmann, Michael , Sabri, Osama , Saur, Dorothee , Schildan, Andreas , Schott, Jonathan M. , Schroeter, Matthias L , Therriault, Joseph , Visser, Denise , Weston, Philip S.J. , Whitwell, Jennifer , Wolk, David A. , Franzmeier, Nicolai , Ossenkoppele, Rik

Mayo Clinic

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093663 Get It

AbstractBackgroundThere is a strong link between tau and progression of Alzheimer’s disease (AD), necessitating an understanding of tau spreading mechanisms. Prior research, predominantly in typical AD, suggested that tau propagates from epicenters (regions with earliest tau) to functionally connected regions. However, given the constrained spatial heterogeneity of tau in typical AD, validating this connectivity‐based tau spreading model in AD variants with distinct tau deposition patterns is crucial.MethodWe included 269 amyloid‐ß‐positive (PET/CSF) individuals with clinically diagnosed atypical AD (113 posterior cortical atrophy, PCA‐AD; 83 logopenic variant primary progressive aphasia, lvPPA‐AD; 33 behavioural variant AD, bvAD; 40 corticobasal syndrome, CBS‐AD) and 68 with typical AD from 12 international cohorts, who underwent tau‐PET (54% [18F]AV1451/[18F]flortaucipir/Tauvid, 27% [18F]MK6240, 19% [18F]PI2620). Using Gaussian mixture modeling including amyloid‐ß‐negative controls, cross‐sectional tau‐PET standardized uptake value ratios within Schaefer‐200 atlas regions were transformed to tau positivity probabilities. Tau epicenters were defined as the 5% regions with highest tau positivity probabilities. For each variant, the association between functional connectivity‐based distance (using the 30% strongest positive region‐to‐region connections of a group‐average connectivity matrix from ADNI elderly controls) and tau‐PET covariance (group‐average correlation per region pair) was assessed through linear regression, adjusting for age, sex, site, and Euclidean distance. Regions were categorized based on functional proximity to the epicenter (quartiles 1‐4) and tau positivity probabilities were assessed accordingly.ResultTau positivity probabilities matched clinical variants, with a posterior pattern in PCA‐AD, left‐hemispheric dominant pattern in lvPPA‐AD, widespread pattern in bvAD, sensorimotor cortex involvement in CBS‐AD, and temporo‐parietal predominance in typical AD (Fig.1). In line with this, tau epicenters were highly heterogeneous across variants (Fig.1). In all variants, greater tau‐PET covariance was associated with shorter functional connectivity‐based distance (Fig.2). We observed that regions in closer functional proximity to the epicenter exhibited higher tau positivity probabilities than regions functionally further away (p<0.05, Fig.3).ConclusionThis multi‐center study shows that the brain’s functional architecture serves as a universal predictor of tau spreading in AD. Since tau is a key driver of neurodegeneration and cognitive decline in AD, this finding holds potential for personalized medicine and defining participant‐specific endpoints in clinical trials.
The Impact of “Close Margins” in HPV‐Associated Oropharyngeal Squamous Cell Carcinoma Treated With TORS
Calcano, Gabriela A. , Rourk, Katelyn S. , O’Byrne, Jamie, García, Joaquín J. , Tasche, Kendall K. , Moore, Eric J. , Abel, Kathryn M. Van , O'Byrne, Jamie J, Van Abel, Kathryn M , Yin, Linda X , Routman, David M. , Chintakuntlawar, Ashish V. , Price, Daniel L. , Yin, Linda X.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 7, 2025 | Volume: 172 | Issue: 4 | Pages: 1291-1299

10.1002/ohn.1127 | PMID 39764676 Get It

Abstract Objective Margin distance is a significant prognosticator in oral cavity cancer but its role in HPV‐related oropharyngeal squamous cell carcinoma [HPV(+)OPSCC] remains unclear. Here, we investigate the impact of margin distance on locoregional recurrence in HPV(+)OPSCC. Study Design This is a retrospective cohort study of surgically treated HPV(+)OPSCC patients. Patients received either standard of care (at least 60 Gy with or without cisplatin) or de‐escalated adjuvant therapy (30‐36 Gy with concurrent docetaxel). Margin distance was measured in mm from the primary specimen or in combination with separately submitted margins. Kaplan‐Meier survival analysis with univariate and multivariable Cox regressions were conducted to determine the impact of margin distance on risk of local and locoregional recurrence. Setting Setting for this is 3 tertiary centers between January 2010 and February 2024. Results Among 1102 included patients, 33 (3.0%) had positive final margins. 374 patients had adequate margin distance data available. Margin distance was >3 mm in 73.4%, 1 to 3 mm in 24.5%, and <1 mm in 2.2% of patients. Positive final margins, pT4 disease, pN2 disease, and surgery alone as a treatment modality ( P < .02 for all) was associated with higher risk of 5‐year locoregional recurrence. Margin distance did not significantly impact risk of local or locoregional recurrence even after adjusting for de‐escalated adjuvant therapy ( P > .05). Conclusion Positive final margins after TORS without adjuvant radiotherapy for HPV(+)OPSCC carries a high risk of local recurrence. Margin distance does not appear to significantly impact risk of local or locoregional recurrence, even after de‐escalated adjuvant radiotherapy.
Prognostic gene expression and microRNA profiling signatures and genetic alterations in primary testicular diffuse large B-cell lymphoma
Young, Ken H. , Jia, Youchao, Tzankov, Alexandar , Go, Heounjeong , Li, Ling , Zhai, Qiong-Li , Perry, Anamarija M. , Wang, Shi , Wang, Xiaoxiao , Chiu, April , Xu, Mina L. , Visco, Carlo , Yuan, Alyssa F. , Miao, Yi , Li, Jianyong , Shuai, Wen , Wang, Bangchen , Pan, Zenggang , Chen, Weina , Zhang, Shanxiang , Sohani, Aliyah R. , Ferreri, Andrés J.M. , Xu, Bing , Young, Ken H , Tzankov, Alexandar , Go, Heounjeong , Xu, Mina , Dybkaer, Karen , Withers, Henry , Li, Jianyong , Bhagat, Govind , Chen, Weina , Møller, Michael Boe , Zhan, Fenghuang , Sohani, Aliyah , Ferreri, Andrés J M , Xu, Bing , Li, Yong , Wang, Bangchen , Shi, Wenyu , Xu‐Monette, Zijun Y. , Ponzoni, Maurilio , Wang, Yafei , Dybkær, Karen , Long, Mark D. , Macias, Everardo , Bhagat, Govind , Zu, Youli , Choi, William, Montes‐Moreno, Santiago , Krieken, J. Han van , Møller, Michael , Zhan, Fenghuang , Parsons, Benjamin M. , Hsi, Eric D. , Abramson, Jeremy S. , Li, Yong

Mayo Clinic

No container title available | January 6, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-5732026/v1 | PMID 39866884 Get It

Abstract Primary testicular diffuse large B-cell lymphoma (PT-DLBCL) is a rare and aggressive lymphoma with molecular heterogeneity not well characterize. In this study, we performed next-generation sequencing analysis for a large number of DNA and RNA samples from patients with PT-DLBCL. DNA sequencing analysis identified ≥ 3 chromosomes with copy number variations (CNVs) and microsatellite instability as prognostic biomarkers, rather than MYD88 mutations and genetic subtypes. Remarkably, targeted RNA-seq analysis in 195 patients revealed that TP53 mutations with a ≥ 40% variant allele frequency had significantly adverse prognostic impact, and that a 150-gene expression signature subdivided PT-DLBCL into two distinct clusters, termed as testicular lymphoma tumor (TLT) and microenvironment (ME) subtypes. The TLT subtype featured upregulation of genes involved in B-cell receptor signaling, cell cycle, DNA damage and repair, higher frequencies of CNVs and MYD88 mutations, elder ages, larger tumor sizes, and significantly poorer survival. Genomic microRNA profiling analysis identified significantly differentially expressed microRNAs between 113 PT-DLBCL and 180 systemic DLBCL patients, and further subdivided the PT-DLBCL cohort by microRNA signatures. The subcohort with upregulation of 16 microRNAs associated with PT-DLBCL and testicular tissue expression had significantly better survival. This study revealed characteristic genetic, gene expression, and microRNA profiles and heterogeneity in PT-DLBCL.
Association of Smokeless Tobacco Use With Perioperative Complications and Revision Surgery After Anterior Cruciate Ligament Reconstruction
Holle, Alejandro M. , Tummala, Sailesh V. , Pejic, Jelena , Schuyver, Paul Van , Economopoulos, Kostas J. , Holle, Alejandro , Tummala, Sailesh V , Chhabra, Anikar

Mayo Clinic

The American Journal of Sports Medicine | January 4, 2025 | Volume: 53 | Issue: 2 | Pages: 308-314

10.1177/03635465241303487 | PMID 39754412 Get It

Background: Tobacco use is a known modifiable risk factor for postoperative complications and revision surgery after anterior cruciate ligament reconstruction (ACLR). Previous studies focus on tobacco as a broad categorization of traditional smoking, smokeless tobacco, and other forms of nicotine use. It is unclear if differences in the type of nicotine used lead to similar adverse outcomes after ACLR. Purposes: To (1) assess the incidence of postoperative complications among ACLR patients who use smokeless tobacco and (2) compare these outcomes with those of patients who do not use tobacco and those who smoke tobacco. Study Design: Cohort study; Level of evidence, 3. Methods: A retrospective cohort study utilizing the PearlDiver database was conducted. Patients undergoing primary ACLR with a minimum 2-year follow-up were included. Smokeless tobacco users (n = 898), cigarette smokers (n= 22,062), and non–tobacco users (n= 207,462) were matched based on patient variables and comorbidities. Postoperative complications within 90 days of surgery and subsequent knee surgery within 2 years were compared among groups. Multivariable logistic regressions were used to control for confounding variables. Results: Compared with nonusers, smokeless tobacco users demonstrated an increased risk of pneumonia (odds ratio [OR], 3.36; 95% CI, 1.41-7.90), acute kidney injury (OR, 12.7; 95% CI, 3.77-52.8), and emergency department (ED) utilization (OR, 6.29; 95% CI, 3.70-10.9) within 90 days of the ACLR. Additionally, smokeless tobacco users had an increased risk of ACLR (OR, 4.75; 95% CI, 3.60-6.26) and meniscal surgery (OR, 2.89; 95% CI, 2.23-3.73) within 2 years. When compared with cigarette smokers, smokeless tobacco users showed an increased risk of pneumonia (OR, 3.25; 95% CI, 1.33-7.78), acute kidney injury (OR, 7.63; 95% CI, 2.72-22.5), and ED visits (OR, 1.55; 95% CI, 1.26-1.90) within 90 days and subsequent ACLR (OR, 4.81; 95% CI, 3.58-6.47) and meniscal surgery (OR, 3.23; 95% CI, 2.45-4.26) within 2 years. Conclusion: Smokeless tobacco use was associated with an increased risk of medical complications, ED utilization, and subsequent procedures compared with nonuser controls and traditional smokers. These findings highlight the importance of considering specific forms of tobacco use in preoperative screening for patients undergoing ACLR.
Solving climate change requires changing our food systems
Feigin, Svetlana , Wiebers, David O. , Blumstein, Daniel T. , Knight, Andrew , Eshel, Gidon , Lueddeke, George R., Kopnina, Helen , Brainin, Michael, Alexander, Shelley M., Merskin, Debra , Kleef, Gerben A. van , Freeman, Carrie Packwood , Feigin, Valery L. , Morand, Sergé , Lee, Kelley , Shackelford, Todd K. , Marcum, James A. , Skerratt, Lee Francis , Whitfort, Amanda S. , Winkler, Andrea Sylvia

Mayo Clinic

Oxford Open Climate Change | January 3, 2025 | Volume: 5 | Issue: 1 | Pages: No page available

10.1093/oxfclm/kgae024 Get It

Abstract Humanity is facing an important existential threat—irreversible climate change caused by human activity. Until recently, most of the proposals to address climate change have downplayed or ignored the adverse impact of food systems, especially intensive animal agriculture. This is in spite of the fact that up to a third of global greenhouse gas production to date can be attributed to animal agriculture. Recent developments at COP28 have signaled that the tide is turning, however, and that food systems are becoming part of global discussions on climate change solutions. The pressing nature of irreversible climate change requires rethinking our food systems. To solve the climate change crisis, we propose transitioning to a predominantly plant-based diet, and phasing out intensive animal agriculture as diets shift, without increasing pastoral farming. We suggest that such transformations in global food systems can be accomplished largely through education and large-scale public information campaigns, removal of subsidies, taxation to account for externalized costs of animal agriculture, improved labelling of products, and various investment/divestment drivers. Better metrics and industry benchmarks involving food and agriculture-specific performance indicators that reflect food system sustainability will be important. Increased global awareness of these issues and a change in mindset (which will drive political will) also are needed. Our current trajectory is untenable, and we must begin to turn the ship now towards sustainable food systems and diets.
An AluYb8 mobile element characterises the risk haplotype of the TMEM106B locus associated with neurodegeneration
Salazar, Alex , Knoop, Lydian, Wijesekera, Sanduni, Hiltunen, Mikko, Petrucelli, Leonard , Hulsman, Marc , Tesi, Niccoló , Pijnenburg, Yolande A.L. , Lee, Sven J. van der , Křížová, Jana , Daμμe, Markus , Reinders, Marcel J. T. , Holstege, Henne H.

Mayo Clinic

Alzheimer's & Dementia | January 3, 2025 | Volume: 20 | Issue: S1 | Pages: No page available

10.1002/alz.090857 Get It

AbstractBackgroundThe TMEM106B protein is critical for proper functioning of the endolysomal system, which is utilised by all cells to traffic and degrade molecular cargo. Genome‐wide association studies identified a haplotype in the TMEM106B gene that is associated with increased risk for Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and frontotemporal lobar degeneration with TAR DNA binding protein inclusions (FTLD‐TDP). However, the causal variant that drives the association has thus far remained elusive.MethodsWe generated long‐read whole‐genome sequencing data of 256 individuals, primarily from Dutch descent. We characterized SNPs and larger structural variants in the TMEM106B locus using de novo genome assembly.ResultsWe identified an insertion of an AluYb8 retrotransposon in the 3’ UTR of TMEM106B gene, that was in complete linkage with the TMEM106B risk‐SNP. AluYb8 retrotransposons have the propensity to propagate through our genomes by utilising a ‘copy‐paste’ mechanism, and once integrated can disrupt transcription and translation of nearby genes. However, propagation of retrotransposons can be suppressed by methylation of the insert and its surrounding regions. Indeed, we observed that the risk haplotype with the AluYb8 insertion, but not the protective haplotype, accumulated CpG islands over evolutionary time. Notably, we observed similar retrotransposon insertions in the 3’ UTR of TMEM106B orthologs in non‐primate species. This suggests a survival advantage, which may be explained by recent findings that TMEM106B is an entry‐receptor for specific viruses in lung‐tissue, such that SINE‐mediated downregulation of TMEM106B may limit viral infection‐load across species.ConclusionsWe speculate that AluYb8‐mediated downregulation of TMEM106B may be protective at younger ages in lung tissues, but that at advanced ages its downregulation in the brain may contribute to increased risk of neurodegenerative diseases. Furthermore, next to the supression of AluYb8 activation by DNA methylation, it may also be suppressed by TDP‐43, in its role in post‐translational RNA‐processing. This leads us to further speculate that age‐related demethylation and age‐related dysregulation of TDP‐43 may result in a negative feedback loop that ultimately reduces the endolysosomal activity in cells. We argue that such a mechanism would explain why increased age is among the strongest risk factors of neurodegenerative diseases.